Syncom Formulations India Ltd. Announces Trading Window Closure for Audited Financial Results

Syncom Formulations India Ltd. has announced the closure of its trading window from 1st April 2026 till completion of 48 hours after the declaration of Audited Standalone & Consolidated Financial Results for the Quarter and Year ended on 31st March 2026. This decision is in accordance with SEBI (Prohibition of Insider Trading) Regulation, 2015 and BSE circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019. The company is required to give prior intimation to the designated depository appointed by the company, i.e. CDSL, at least 2 trading days prior to the commencement of the trading window. All Promoter and Promoter group, Directors, KMP’s, Designated Persons/Employees, Connected Persons, Fiduciaries of the Company and their immediate relatives are advised not to deal in the shares of the Company either directly or indirectly during the aforesaid period. The date of the meeting of the Board of Directors to approve the Audited Standalone & Consolidated Financial Results for the Quarter and Year ended on 31st March 2026 will be informed in due course.